Syeda Ahmad, MD, Recruited to Provide Specialized Care for Glomerular Disease

October 15, 2020

The UPMC Kidney Disease Center is pleased to announce the newest addition to our team, Syeda Behjat Ahmad, MD. 

Working closely with Duncan Johnstone, MD, clinical director of UPMC Nephrology, Dr. Ahmad will be developing a specialized clinic for patients with glomerular disease. The clinic will focus on rare kidney diseases such as membranous, minimal change, lupus, focal and segmental glomerulosclerosis, IgA Nephropathy, Alport’s Syndrome, and other genetic causes of kidney dysfunction. 

Dr. Ahmad completed her nephrology training at UPMC in 2019 as chief nephrology fellow. At Columbia University College of Physicians and Surgeons, she completed her glomerular disease fellowship. 

Recent Publications 

Disaster Response to the COVID 19 Pandemic for Patients with Kidney Disease in New York City. JASN, July 2020, 31 (7) 1371-1379; DOI: https://doi.org/10.1681/ASN.2020040520

C3 Glomerulopathy: Pathogenesis and Treatment. ACKD, June 15, 2020. DOI: https://doi.org/10.1053/j.ackd.2019.12.003 

How COVID 19 changed the management of Glomerular Diseases. CJASN ,June 2020, 15 (6) 876-879; DOI: https://doi.org/10.2215/CJN.04530420

Acute Kidney Injury due to Collapsing Glomerulopathy Following COVID 19 Infection. Kidney International Reports, April 27, 2020; DOI: https://doi.org/10.1016/j.ekir.2020.04.017

Antigens, Antibodies, and membranous nephropathy: A decade of progress. Kidney International, Jan 2020; DOI: https://doi.org/10.1016/j.kint.2019.10.009


Interested in receiving specialty-specific information? Register for UPMC Physician Resources to get emerging research, clinical updates, and free CME straight to your inbox.